Composition comprising FUT2-dependent oligosaccharides and lacto-N-neotetraose for use in promoting brain development and cognition
A nutritional composition contains Fut2-dependent oligosaccharides for promoting brain growth and development in infants in the very early postnatal period. The nutritional composition contains Fut2-dependent oligosaccharides and Lacto-N-neotetraose and is specifically for use in promoting brain catch-up growth in preterm infants or infants with low-birth weight. A kit can include at least two of these nutritional compositions.
1. A method for promoting head circumference growth rate in an infant between 0 and 1 month of age in need thereof, the method comprising administering a nutritional composition comprising Lacto-N-Neotetraose (LNnT) and an effective amount of 2′Fucosyllactose (2′FL) to the infant, the nutritional composition does not contain probiotics, wherein the infant was born from a mother having breast milk with a 2′FL concentration of less than 0.2 g/L.
2. The method according to claim 1 , wherein the nutritional composition is administered to the infant in an amount effective for achieving an additional characteristic selected from the group consisting of brain catch-up growth in infants, cognitive function in infants, psychomotor development in infants, and any combination thereof.
3. The method according to claim 1 , wherein the nutritional composition provides nutrition to the infant.
4. The method according to claim 1 , wherein the nutritional composition is administered to the infant in addition to breast feeding.
5. The method according to claim 1 , wherein the Lacto-N-Neotetraose (LNnT) is 0.1 to 0.6 g/L of the nutritional composition.
6. The method according to claim 1 , wherein the nutritional composition further comprises at least one additional Fucosyltransferase 2 (Fut2)-dependent oligosaccharide selected from the group consisting of di-Fucosyllactose (diFL) and Lacto-N-fucopentaose I (LNFP I).
7. The method according to claim 1 , wherein the nutritional composition is in a form selected from the group consisting of an infant formula, a preterm infant formula, a human milk fortifier, a starter infant formula, a follow-on formula, a baby food formula, a medical food product for clinical nutrition and a supplement.
8. The method according to claim 1 , wherein the infant was born preterm or with low-birth weight or experienced intra-uterine growth retardation or suffered from growth stunting because of malnutrition and/or a disease.
9. The method according to claim 1 , wherein the Lacto-N-Neotetraose (LNnT) is 0.30 to 0.35 g/L of composition, and the 2′Fucosyllactose (2′FL) is 2.0 to 2.2 g/L of the nutritional composition.
10. The method according to claim 1 , further comprising adding the nutritional composition to breast milk from the mother of the infant prior to the administering.
11. A method to provide nutrition to an infant between 0 and 1 month of age in need of brain catch-up growth, the method comprising feeding a nutritional composition comprising Lacto-N-Neotetraose (LNnT) and an effective amount of 2′Fucosyllactose (2′FL) to the infant, the nutritional composition does not contain probiotics.
12. The method of claim 11 , wherein the infant was born from a mother with a 2′FL concentration in the breast milk of the mothers of less than 0.2 g/L.
13. The method of claim 11 , wherein the nutritional composition is administered to the infant in an amount effective for achieving a characteristic selected from the group consisting of head circumference growth rate in infants, brain catch-up growth in infants, cognitive function in infants, psychomotor development in infants, and any combination thereof.